CVM - CEL SCI CORP
3.94
-0.060 -1.523%
Share volume: 63,790
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.00
-0.06
-0.02%
View ratios
| Fiscal Date | 12-31-2023 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
| Report Date | 02-14-2025 | 08-14-2024 | 02-14-2025 | 02-14-2025 | 05-14-2025 | 08-14-2025 | 02-17-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 6.486 M | 6.670 M | 6.120 M | 6.893 M | 6.394 M | 5.489 M | 5.369 M | |
| Selling general and admin | 2.133 M | 1.967 M | 1.643 M | 2.463 M | 2.380 M | 1.749 M | 1.692 M | |
| Research and development | 4.353 M | 4.703 M | 4.477 M | 4.430 M | 4.014 M | 3.740 M | 3.677 M | |
| Total expenses | 6.486 M | 6.670 M | 6.120 M | 6.893 M | 6.394 M | 5.489 M | 5.369 M | |
| 2.84% | -8.24% | 12.63% | -7.24% | -14.16% | -2.19% | |||
| Operating income | -6.486 M | -6.670 M | -6.120 M | -6.893 M | -6.394 M | -5.489 M | -5.369 M | |
| Ebit | -6.486 M | -6.670 M | -6.120 M | -6.893 M | -6.394 M | -5.489 M | -5.369 M | |
| Pretax income | -6.684 M | -6.861 M | -6.647 M | -7.064 M | -6.572 M | -5.661 M | -5.457 M | |
| 2.65% | -3.12% | 6.27% | -6.95% | -13.87% | -3.61% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.710 M | -6.857 M | -6.109 M | -7.073 M | -6.572 M | -5.665 M | -5.469 M | |
| -2.19% | 10.90% | -15.77% | 7.08% | 13.81% | 3.45% |